Stockreport

Progenity to Participate in the Raymond James 2021 Human Health Innovation Conference

Biora Therapeutics, Inc.  (PROG) 
PDF SAN DIEGO, June 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that Harry Stylli, PhD, CEO, chairman [Read more]